Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/all.14824 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spontaneous and induced degradation of dermal fillers: A review.
J Cutan Aesthet Surg
November 2023
Department of Plastic Surgery, Hospital São Lucas da PUCRS, Porto Alegre, Brazil.
Dermal fillers are among the most versatile tools in esthetic medicine. A broad range of temporary, semipermanent, and permanent filler products are on the market. We performed a narrative review on spontaneous and induced degradation of dermal fillers and .
View Article and Find Full Text PDFInter-societal Survey on the topical nasal treatments in Italy.
Multidiscip Respir Med
December 2024
Casa di Cura Villa Montallegro.
Topical nasal therapy represents a widespread opportunity to treat upper airway diseases. As a result, specialists in different areas (mainly ENT, pediatrics, and allergology) and general practitioners prescribe intranasal compounds. However, a myriad of products and devices are available, as well as respiratory disorders.
View Article and Find Full Text PDFCo-culture of human AT2 cells with fibroblasts reveals a MUC5B phenotype: insights from an organoid model.
Mol Med
November 2024
Department of Internal Medicine V - Pulmonology, Allergology and Critical Care Medicine, Saarland University, 66421, Homburg, Germany.
Article Synopsis
- Impaired interaction between fibroblasts and AT2 pneumocytes contributes to chronic lung diseases like idiopathic pulmonary fibrosis (IPF), with Mucin 5B (MUC5B) being associated with the condition.
- Research using an organoid model showed that fibroblasts with high fibrosis markers can alter STAT3 signaling in AT2 cells, leading to cystic growth and increased MUC5B expression, influenced by the cytokine IL-6.
- The study also demonstrated that the drug dasatinib can block the formation of these cystic organoids, suggesting a potential avenue for drug development to address these interactions in IPF.
Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention and Management.
Dermatol Ther (Heidelb)
July 2024
Care Geneva Aesthetics, Geneva, Switzerland.
Hyaluronic acid (HA) dermal fillers, generally considered low-risk, can lead to rare late-onset reactions (LORs) manifesting between 3 and 4 months postinjection, occasionally even as early as 24 h postinjection. The Complication Assessment and Risk Evaluation (CARE) board was established to review these reactions. In this publication, the authors aims to explore the etiological hypotheses underlying LORs, associated risk factors, prevention, and management approaches suggested by the CARE board.
View Article and Find Full Text PDFTriamcinolone Injection in the Treatment of Malar Edema.
Dermatol Pract Concept
April 2024
B City Clinic, Liverpool, England.
Introduction: Tear-through deformities can be a detectable sign of facial aging. Over recent years, minimally invasive procedures such as hyaluronic acid filler injections have been shown to be effective in improving this area. Malar edema is the accumulation of fluid over the malar eminence persisting for 1 month or more.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!